Table 1.
Comparison of baseline characteristics by metabolic syndrome status
| Baseline characteristics | Metabolic syndrome
|
P-value | |
|---|---|---|---|
| Yes (n = 30) | No (n = 50) | ||
| Age group | |||
| 18–39 | 7 (23.3%) | 27 (54.0%) | 0.009 |
| 40–59 | 17 (56.7%) | 20 (40.0%) | |
| ≥60 | 6 (20.0%) | 3 (6.0%) | |
| Sex | |||
| Male | 12 (40.0%) | 22 (44.0%) | 0.726 |
| Female | 18 (60.0%) | 28 (56.0%) | |
| Marital status | |||
| Single | 15 (50.0%) | 37 (74.0%) | 0.003 |
| Married | 9 (30.0%) | 10 (20.0%) | |
| Widow or separated | 6 (20.0%) | 3 (6.0%) | |
| Duration of illness (years) | |||
| 0–10 | 10 (33.3%) | 30 (60.0%) | 0.027 |
| 11–20 | 11 (36.7%) | 15 (30.0%) | |
| >20 | 9 (30.0%) | 5 (10.0%) | |
| Alcohol drinker | |||
| Yes | 5 (16.7%) | 6 (12.0%) | 0.557 |
| No | 25 (83.3%) | 44 (88.0%) | |
| Current smoker | |||
| Yes | 4 (13.3%) | 9 (18.0%) | 0.584 |
| No | 26 (86.7%) | 41 (82.0%) | |
| Current treatment | |||
| Second-generation antipsychotics | 17 (56.7%) | 18 (36.0%) | 0.071 |
| First-generation antipsychotics | 13 (43.3%) | 32 (64.0%) | |
| PANSS variables (mean ± SD) | |||
| PANSS total score | 46.3 ± 13.1 | 45.2 ± 12.4 | 0.699 |
| PANSS positive symptoms | 10.7 ± 3.6 | 10.8 ± 4.0 | 0.921 |
| PANSS negative symptoms | 12.2 ± 5.0 | 11.5 ± 3.9 | 0.535 |
| PANSS general psychopathology | 23.4 ± 6.4 | 22.9 ± 5.9 | 0.691 |
Abbreviations: PANSS, Positive and Negative Syndrome Scale; SD, standard deviation.